Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on April 22, 2025

Galatea Bio joins iHope Genetic Health Program, Expanding Access to Genomic Testing for Underserved Families
Galatea Bio joins iHope to expand free genomic testing for underserved families, advancing global health equity through precision medicine. DAMASCUS, MD, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- Genetic Alliance is pleased to announce the …

The Impact of Footwear on Spine Health: Experts Warn About the Link Between Shoes and Back Pain
JACKSONVILLE, FL, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- Back pain is often attributed to factors such as poor posture, stress, or heavy lifting. However, an often overlooked contributor to discomfort may lie in the shoes worn on a daily …

Mirasys Expands Proven Casino & Government-Grade Security to Safeguard Healthcare Workers Amid Rising Violence
Healthcare workers are subject to workplace violence - This Advanced VMS Solution Can Minimize the Threat NEW YORK, FL, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- After years of delivering mission-critical security solutions for casino …

Exclusive Interviews: EIN Presswire Delves Into the Compelling Journeys of Top PR Pros
Q…

Domestically Sourced HEPA Filter Production Amid Supply Chain Uncertainty
Insert molding for HEPA filtration, designed to enhance the efficiency and performance of filtration systems MCHENRY, IL, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- Superior Felt …

Penta Security Expands Cloudbric Managed Rules for AWS WAF to Two New Regions
SEOUL, SEOUL, SOUTH KOREA, April 22, 2025 /EINPresswire.com/ -- Penta Security, a leading cyber security company and provider of web application security in the Asia-Pacific region, has expanded the service region for Cloudbric Managed Rules for AWS WAF …

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of …

Clover Health Announces Changes to Board of Directors
WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that after four years of distinguished service, Lee A. Shapiro, a member of Clover Health’s …

Natural Mounjaro Recipe for Weight Loss: The Best OTC Tirzepatide Alternative, Slimjaro
Lakeland, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- Slimjaro Emerges as the Leading Natural Mounjaro Recipe for Weight Loss in 2025—Delivering a Powerful OTC Tirzepatide Alternative Without the Injections, Prescription Costs, or Side Effects Introduction …

UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first …

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025
DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and full year financial results at 9:00 a.m. ET on May 15, …

Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details
LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its First …

The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials
CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), a pioneer in value-based community oncology care, is proud to announce an enterprise-wide expansion of its strategic partnership with …

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones Annual General Meeting scheduled for Friday, June 6, 2025, in Paris, France Phase 3 ABTECT induction trials remain on track: enrollment completion …

Sight Sciences Appoints Gary Burbach to its Board of Directors
MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the …

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief Scientific Officer, will participate in …

Intuitive Announces First Quarter Earnings
SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March …

NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario
TORONTO and HAIFA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering regenerative exosomes-based therapies for central …

Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025
MIAMI, April 22, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the Company …

Mesmerize honored with 2025 Pharmacy500 award by RXinsider
NEW YORK, NY, April 22, 2025 (GLOBE NEWSWIRE) -- Mesmerize, an MJH Life Sciences® brand and a leader in patient education at the point of care, is proud to announce that it has been named to the prestigious 2025 Pharmacy500, an annual award presented by …